8-K ·Filed Apr 27, 2026

AGL

agilon health, inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001628280-26-027512
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Monitor the proxy fight outcome as it could influence strategic direction; the hefty PSU targets suggest management's optimism about stock price recovery, but near-term focus should be on the contested board election results.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
AGL ▲ +259.39% at T+60d
NEUTRAL call ✓ call won +259.39% · α vs SPY +255.40% · entry $27.90 → $100.27
Entry anchored
Apr 27, 03:59 PM ET
via exchange tick
T+1d
-8.46%
call -8.46% · α -8.45%
$25.54
settled 5mo ago
T+5d
-3.44%
call -3.44% · α -5.13%
$26.94
settled 5mo ago
T+20d
+205.63%
call +205.63% · α +200.16%
$85.27
settled 4mo ago
T+60d
+259.39%
call +259.39% · α +255.40%
$100.27
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

agilon health appointed Tim O'Rourke as CEO and President, effective May 7, 2026, with a compensation package including $850,000 base salary, $500,000 signing bonus, and equity awards tied to aggressive stock price targets. The appointment comes amid a proxy fight context (DEFA14A filed 4 days prior), suggesting potential board-level tensions.

Key Facts

  • Tim O'Rourke appointed CEO and President, starting May 7, 2026
  • Base salary of $850,000 with 100% target annual bonus opportunity
  • One-time cash signing bonus of $500,000
  • Granted 120,000 time-vesting RSUs (3-year vesting) and 200,000 performance-vesting PSUs with stock price targets of $50, $100, and $150
  • Severance: 18 months of base salary plus target bonus upon without-cause termination
  • Cross-filing: DEFA14A (proxy fight materials) filed April 23, 2026, indicating contested board election

Financial Impact

CEO compensation disclosed; no financial performance impact directly from this filing

executive compensation

Risk Factors

  • Proxy fight may distract management or lead to board changes
  • Aggressive PSU targets may signal unrealistic expectations
  • Stock price is low ($435M market cap); PSU targets far above current levels could be dilutive if not met

Market Snapshot

Exchange
NYSE
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
8% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-027512
Exhibit: ex-991.htm0001628280-26-027512
Document: 0001628280-26-027512-index-headers.html0001628280-26-027512
Document: 0001628280-26-027512-index.html0001628280-26-027512
Document: 0001628280-26-027512.txt0001628280-26-027512
4 reports for AGL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AGL — sortable, filterable
TypeNow
Apr 27, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$27.90 $100.27▲ +259.39%▲ +255.40%$84.63 (+203.33%)
Apr 27, 2026
22w ago
8-K
NEUTRAL ★ 4/10
$27.90 $100.27▲ +259.39%▲ +255.40%$84.63 (+203.33%)
Feb 28, 2026
30w ago
Institutional Cluster
BULLISH ★ 6/10
$15.40 $85.27▲ +453.70%▲ +444.37%$84.63 (+449.55%)
Feb 25, 2026
31w ago
8-K
MIXED ★ 6/10
$12.50 $80.94▲ +547.52%▲ +540.57%$84.63 (+577.04%)
Showing 4 of 4

US Market Status

Market Open — Closes in 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access